More importantly, we show that genetic inhibition of tp53 can suppress neuroepithelial cell death and ameliorate the cranioskeletal anomalies in polr1c-/- and polr1d-/- mutants, providing a potential avenue to prevent the pathogenesis of TCS. This evidence concerns the gene POLR1D and Treacher-Collins syndrome.